Ledger.Open graph →
SEC Form D · filed December 11, 2015

Thrive Bioscience, Inc

Offering
$2.2M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Beverly, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Michael P. Finney · Beverly, MADirectorThomas F. Farb · Beverly, MAExec · DirectorAlan P. Blanchard · Beverly, MAExec · DirectorPeter M. Carlton · Los Angeles, CAExec · DirectorRobert A. Day · Los Angeles, CADirectorAndrew K. Tsai · New York, NYExec · DirectorBrock P. Reeve · Beverly, MADirectorGuy P. Broadbent · Beverly, MADirectorAndrew Katz · New York, NYExec · DirectorDave Myers · New York, NYDirectorMichael Katz · New York, NYExec · DirectorBrock P. Reeve · Beverly, MADirectorGuy P. Broadbent · Beverly, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗